Iron Deficiency Anemia is the most common type of anemia that is characterized by a lack of iron; this can be majorly due to low consumption of iron, or blood loss, the inability of the patient’s body to absorb iron, blood loss, comorbid condition, and others.
DelveInsight’s Iron Deficiency Anemia Market report offers comprehensive coverage of the current treatment practices, pipeline drugs, Iron Deficiency Anemia market share of the individual therapies, current and forecasted Iron Deficiency Anemia market size from 2018 to 2030 segmented into 7MM (the USA, EU5 (the UK, Italy, Spain, France, and Germany), and Japan).
Some of the key takeaways from the Iron Deficiency Anemia Market report:
Discover more about therapy set to grab substantial market share @ Iron Deficiency Anemia Market Share
Iron Deficiency Anemia Epidemiology
IDA is often underdiagnosed and undertreated, as some people may not have any symptoms at first; however, it accounts for approximately half of all the global Anemia cases. The Iron Deficiency Anemia market report puts forward the IDA epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
Download report to understand which demographic factors are guiding the CRC epidemiology trends @ Iron Deficiency Anemia Epidemiological Insights
Iron Deficiency Anemia Therapy Market
The goal of Iron Deficiency Anemia treatment is to increase iron intake in the body via an iron-rich diet and oral iron supplements that can help treat the majority of mild-to-moderate IDA cases. DelveInsight analyzed that in the 7MM, approximately 9,266,923 patients received first-line oral therapies in 2020. The second-line oral medications available in the Iron Deficiency Anemia market comprises Oral Ferrous Products (OFPs) such as Feraccru (Accrufer) and Auryxia (Riona). These are the most common treatment options and constitute approximately 10-15% of the total IDA market share. In cases where the first and second line of therapies fail to produce outcomes, IV iron therapy is administered.
Iron Deficiency Anemia Marketed Therapies
Learn more about available treatments @ Iron Deficiency Anemia Drugs & Therapies
Iron Deficiency Anemia Market Landscape
The Iron Deficiency Anemia market landscape is anticipated to change during the forecasted period attributable to the launch of emerging therapies and the influx of several Pharma and biotech companies in the IDA market during the forecasted period of 2021–2030. The recent launch of Accrufer in July 2021, a therapy by Shield Therapeutics in the US market for the treatment of adults with low iron stores, projects a rich and promising picture of the IDA market with demand for novel therapeutic agents rising in the coming years.
Iron Deficiency Anemia Pipeline Analysis
MPB-1514: MegaPro Biomedical
IDAX (IHAT-02): Nemysis
Triferic: Rockwell Medical
Iron Deficiency Anemia Market: Drivers and Barriers
An increase in the IDA prevalence is a major driving force behind the surge of the IDA market size growth in the coming years. Further, the condition is also a result of other health-related factors such as pregnancy, cancer, or IBD that is adding to the burden. The Iron Deficiency Anemia market has also witnessed an increase in the clinical trial activity with novel therapeutic assets in the investigation in different stages of development, which is further expected to bring different therapies in the market. The Iron Deficiency Anemia market is a volume-driven market and there exist lucrative opportunities for the drugs to get the broader label which will provide a larger window for the drugs to act.
However, the IDA market appears to be dominated by cheap prescription and OTC drugs, and DelveInsight estimates an increase in the volume of the generics in the market that is going to pose a challenge in the uptake of novel IDA pipeline therapies. However, available oral iron products usually take a long time to show results, have side effects, are less efficient and IV drugs require physical visits of patients to health care centres with chances of injection site reactions, side effects and iron overdose; this paves way for Pharma companies to take advantage and tap opportunities present in the market and develop a neon-Drugs oral drug with less GI side effects, better absorption and efficacy, less dosing frequency, and good tolerability.
Scope of the Iron Deficiency Anemia Market Report
Coverage: 7MM (the US, EU5, and Japan)
Study Period: 2018-30
Key Companies: MegaPro Biomedical, Nemysis, Rockwell Medical, and others.
Key Iron Deficiency Anemia Pipeline Therapies: IDAX, Triferic, MPB-1514, and others.
Iron Deficiency Anemia Market Segmentation: By Geography, By Iron Deficiency Anemia Therapies
Analysis: Comparative and conjoint analysis of Iron Deficiency Anemia emerging therapies
Tools used: SWOT analysis, Conjoint Analysis, Porter’s Five Forces, PESTLE analysis, BCG Matrix analysis methods. Case Studies KOL’s Views Analyst’s Views
Table of Contents
1
Key Insights
2
Iron Deficiency Anemia Market Report Introduction
3
Iron Deficiency Anemia Market Overview at a Glance
4
Executive Summary of Iron Deficiency Anemia
5
Disease Background and Overview
6
Patient Journey
7
Iron Deficiency Anemia Epidemiology and Patient Population
8
Treatment Algorithm, Current Treatment, and Medical Practices
9
Country Wise-Epidemiology of Iron Deficiency Anemia
10
Iron Deficiency Anemia Treatment
11
Unmet Needs
Key Endpoints of IDA Treatment
12
Iron Deficiency Anemia Emerging Therapies
13
Prescription or Over the Counter Drugs (Rx/OTC)
14
Non-Drug Iron Supplements
15
Iron Deficiency Anemia: 7 Major Market Analysis
16
Iron Deficiency Anemia Market Unmet Needs
17
Attribute analysis
18
IDA Market Access and Reimbursement
19
Iron Deficiency Anemia Market Drivers
20
Iron Deficiency Anemia Market Barriers
21
SWOT Analysis
KOL Reviews
22
Appendix
23
DelveInsight Capabilities
24
Disclaimer
25
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and Pharma market research reports through our subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/iron-deficiency-anemia-market